B. Metzler seel. Sohn & Co’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.58M | Hold |
36,603
| – | – | 0.02% | 433 |
|
2025
Q1 | $1.27M | Hold |
36,603
| – | – | 0.01% | 467 |
|
2024
Q4 | $1M | Hold |
36,603
| – | – | 0.01% | 536 |
|
2024
Q3 | $932K | Buy |
36,603
+7,514
| +26% | +$191K | 0.01% | 558 |
|
2024
Q2 | $737K | Hold |
29,089
| – | – | 0.01% | 580 |
|
2024
Q1 | $899K | Sell |
29,089
-19,723
| -40% | -$610K | 0.01% | 538 |
|
2023
Q4 | $1.97M | Buy |
48,812
+5,213
| +12% | +$210K | 0.03% | 370 |
|
2023
Q3 | $1.15M | Sell |
43,599
-37,957
| -47% | -$1M | 0.02% | 438 |
|
2023
Q2 | $1.4M | Buy |
81,556
+27,919
| +52% | +$480K | 0.02% | 436 |
|
2023
Q1 | $889K | Buy |
53,637
+4,367
| +9% | +$72.4K | 0.01% | 457 |
|
2022
Q4 | $375K | Hold |
49,270
| – | – | 0.01% | 597 |
|
2022
Q3 | $490K | Buy |
49,270
+2,624
| +6% | +$26.1K | 0.01% | 545 |
|
2022
Q2 | $424K | Hold |
46,646
| – | – | 0.01% | 579 |
|
2022
Q1 | $473K | Buy |
+46,646
| New | +$473K | 0.01% | 606 |
|